Published August 23, 2023
| Version v1
Journal article
Open
Antibody Characterization Report for SMOC-1
Creators
- 1. Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
- 2. The Neuro's Early Drug Discovery Unit (EDDU), Structural Genomics Consortium, McGill University, Montreal, Quebec, Canada
Description
Head-to-head comparison of available commercial antibodies against SPARC-related modular calcium-binding protein 1(SMOC-1 by immunoblot (Western blot) and immunoprecipitation on culture media. This report can be viewed as a follow-up study to the initial SMOC-1 report released to the YCharOS community (https://doi.org/10.5281/zenodo.6566878) in which the antibodies underwent retesting, with the addition of two new antibodies. Work reported in this report was supported in part by the Accelerating Medicines Partnership Program for Alzheimers Disease (AMD-AD) established by the National Institutes of Aging under award number U54AG065187.
Files
SMOC-1_YCharOS report_v2 .pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:cbdd143eba9f1da174752e2f05d62681
|
1.1 MB | Preview Download |